drugset / Trial / NCT00807794
A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate the clinical safety of different doses of MEDI-507 through day 33.
Timeline
- Start
- 1997-02
- Primary completion
- 1997-11
- Completion
- 1998-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Siplizumab | Monoclonal antibody | 0.012 mg/kg | — |
| Subject | Siplizumab | Monoclonal antibody | 0.06 mg/kg | — |
| Subject | Siplizumab | Monoclonal antibody | 0.12 mg/kg | — |
| Subject | Siplizumab | Monoclonal antibody | 0.24 mg/kg | — |
| Subject | Siplizumab | Monoclonal antibody | 0.5 mg/kg | — |